Genocea Biosciences (GNCA) Tops Q2 EPS by 5c

Genocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.39), $0.05 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• SanDisk upgraded at JPMorgan after investor day; shares climb